The DOI matches its Crossref record; 481 of the 481 references it cites were found in a registry or an index.
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
Open accessAbstract
Cancer is a disease caused by the accumulation of genetic and epigenetic changes in two types of genes: tumor suppressor genes (TSGs) and proto-oncogenes. Extensive research has been conducted over the last few decades to elucidate the role of TSGs in cancer development. In cancer, loss of TSG function occurs via the deletion or inactivation of two alleles, according to Knudson’s two-hit model hypothesis. It has become clear that mutations in TSGs are recessive at the level of an individual cell; therefore, a single mutation in a TSG is not sufficient to cause carcinogenesis. However, many studies have identified candidate TSGs that do not conform with this standard definition, including genes inactivated by epigenetic silencing rather than by deletion. In addition, proteasomal degradation by ubiquitination, abnormal cellular localization, and transcriptional regulation are also involved in the inactivation of TSGs. This review incorporates these novel additional mechanisms of TSG inactivation into the existing two-hit model and proposes a revised multiple-hit model that will enable the identification of novel TSGs that can be used as prognostic and predictive biomarkers of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Roman-Gomez, J., Jimenez-Velasco, A., Castillejo, J. A., Agirre, X., Barrios, M., Navarro, G., Molina, F. J., Calasanz, M. J., Prosper, F., Heiniger, A., et al. (2004) · Blood · doi:10.1182/blood-2004-03-0954 · Cited by 208
RetractedEsteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,739
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Genetic Pathways to Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070011 · Cited by 1,497
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Sukhatme, V. P., Cao, X., Chang, L. C., Tsai-Morris, C.-H., Stamenkovich, D., Ferreira, P. C. P., Cohen, D. R., Edwards, S. A., Shows, T. B., Curran, T., et al. (1988) · Cell · doi:10.1016/0092-8674(88)90485-0 · Cited by 1,250
The IARC TP53 database: new online mutation analysis and recommendations to users
Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., & Hainaut, P. (2002) · Human Mutation · doi:10.1002/humu.10081 · Cited by 1,248
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173
Exportin 1 (Crm1p) Is an Essential Nuclear Export Factor
Stade, K., Ford, C. S., Guthrie, C., & Weis, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80370-0 · Cited by 1,141
KiSS-1, a Novel Human Malignant Melanoma Metastasis-Suppressor Gene
Lee, J.-H., Miele, M. E., Hicks, D. J., Phillips, K. K., Trent, J. M., Weissman, B. E., & Welch, D. R. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.23.1731 · Cited by 1,072
The INK4a/ARF network in tumour suppression
Sherr, C. J. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096061 · Cited by 996
Regulation of PTEN Transcription by p53
Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., & Mak, T. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00323-9 · Cited by 912
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 847
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
Genetic landscape of esophageal squamous cell carcinoma
Gao, Y.-B., Chen, Z.-L., Li, J.-G., Hu, X.-D., Shi, X.-J., Sun, Z.-M., Zhang, F., Zhao, Z.-R., Li, Z.-T., Liu, Z.-Y., et al. (2014) · Nature Genetics · doi:10.1038/ng.3076 · Cited by 694
Dearden, S., Stevens, J., Wu, Y.-L., & Blowers, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt205 · Cited by 646
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Sánchez‐Céspedes, M., Parrella, P., Esteller, M., Nomoto, S., Trink, B., Engles, J. M., Westra, W. H., Herman, J. G., & Sidransky, D. (2002) · PubMed · Cited by 612
Targeting the TGFβ pathway for cancer therapy
Neuzillet, C., Tijeras-Raballand, A., Cohen, R., Cros, J., Faivre, S., Raymond, E., & de Gramont, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.001 · Cited by 611
Inactivation of the p53 pathway in retinoblastoma
Laurie, N. A., Donovan, S. L., Shih, C.-S., Zhang, J., Mills, N., Fuller, C., Teunisse, A., Lam, S., Ramos, Y., Mohan, A., et al. (2006) · Nature · doi:10.1038/nature05194 · Cited by 595
Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L., & Holt, J. T. (1995) · Nature Genetics · doi:10.1038/ng0495-444 · Cited by 585
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.
Brzović, P. S., Rajagopal, P., Hoyt, D. W., King, M., & Klevit, R. E. (2001) · Nature Structural Biology · doi:10.1038/nsb1001-833 · Cited by 573
The genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Missiaglia, E., Dalai, I., Barbi, S., Beghelli, S., Falconi, M., della Peruta, M., Piemonti, L., Capurso, G., Di Florio, A., delle Fave, G., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.5988 · Cited by 536
Esteller, M., Tórtola, S., Toyota, M., Capellá, G., Peinado, M. A., Baylin, S. B., & Herman, J. G. (2000) · PubMed · Cited by 531
Rowan, A. J., Lamlum, H., Ilyas, M., Wheeler, J., Straub, J., Papadopoulou, A., Bicknell, D., Bodmer, W. F., & Tomlinson, I. P. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3352 · Cited by 500
Beyond E-cadherin: roles of other cadherin superfamily members in cancer
van Roy, F. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3647 · Cited by 475
Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover
Henderson, B. R. (2000) · Nature Cell Biology · doi:10.1038/35023605 · Cited by 473
p16(MTS-1/CDKN2/INK4a) in Cancer Progression
Rocco, J. W., & Sidransky, D. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5149 · Cited by 470
INK4a/ARF: A multifunctional tumor suppressor locus
Sharpless, N. E. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.08.021 · Cited by 442
KLF6 , a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer
Narla, G., Heath, K. E., Reeves, H. L., Li, D., Giono, L. E., Kimmelman, A. C., Glucksman, M. J., Narla, J., Eng, F. J., Chan, A. M., et al. (2001) · Science · doi:10.1126/science.1066326 · Cited by 442
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
Miyaki, M., Iijima, T., Konishi, M., Sakai, K., Ishii, A., Yasuno, M., Hishima, T., Koike, M., Shitara, N., Iwama, T., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202642 · Cited by 436
Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p Loss
Cairns, P., Mao, L., Merlo, A., Lee, D. J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J. E., & Sidransky, D. (1994) · Science · doi:10.1126/science.8023167 · Cited by 427
Maruyama, R., Toyooka, S., Toyooka, K. O., Harada, K., Virmani, A. K., Zöchbauer‐Müller, S., Farinas, A. J., Vakar‐Lopez, F., Minna, J. D., Sagalowsky, A. I., et al. (2001) · PubMed · Cited by 422
Nucleocytoplasmic Shuttling of Smads 2, 3, and 4 Permits Sensing of TGF-β Receptor Activity
Inman, G. J., Nicolás, F. J., & Hill, C. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00585-3 · Cited by 417
Su, G. H., Hruban, R. H., Bansal, R. K., Bova, G. S., Tang, D. J., Shekher, M. C., Westerman, A. M., Entius, M. M., Goggins, M., Yeo, C. J., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65440-5 · Cited by 417
Hypermethylation of multiple genes in pancreatic adenocarcinoma.
Ueki, T., Toyota, M., Sohn, T. A., Yeo, C. J., Issa, J. J., Hruban, R. H., & Goggins, M. (2000) · PubMed · Cited by 407
Somatic mutations in the neurofibromatosis 1 gene in human tumors
Li, Y., Bollag, G., Clark, R., Stevens, J., Conroy, L., Fults, D., Ward, K., Friedman, E., Samowitz, W., Robertson, M., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90408-5 · Cited by 395
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
Murakami, Y., Hayashi, K., Hirohashi, S., & Sekiya, T. (1991) · PubMed · Cited by 374
Børresen-Dale, A.-L. (2003) · Human Mutation · doi:10.1002/humu.10174 · Cited by 354
Girard, L., Zöchbauer‐Müller, S., Virmani, A. K., Gazdar, A. F., & Minna, J. D. (2000) · PubMed · Cited by 352
Strathdee, G., MacKean, M. J., Illand, M., & Brown, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202540 · Cited by 350
TP53 mutation in colorectal cancer
Iacopetta, B. (2003) · Human Mutation · doi:10.1002/humu.10175 · Cited by 345
Yamashita, K., Upadhyay, S., Osada, M., Hoque, M. O., Xiao, Y., Mori, M., Sato, F., Meltzer, S. J., & Sidransky, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00215-5 · Cited by 340
Regulatory Mechanisms of Tumor Suppressor P16INK4Aand Their Relevance to Cancer
Li, J., Poi, M. J., & Tsai, M.-D. (2011) · Biochemistry · doi:10.1021/bi200642e · Cited by 334
Transport into and out of the cell nucleus
Gorlich, D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2721 · Cited by 331
Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis
Lee, S., Lee, H. J., Kim, J.-H., Lee, H.-S., Jang, J. J., & Kang, G. H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63495-5 · Cited by 330
Cyclin C/Cdk3 Promotes Rb-Dependent G0 Exit
Ren, S., & Rollins, B. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00300-9 · Cited by 316
(2001) · PubMed · Cited by 309
Asano, T., Yao, Y., Zhu, J., Li, D., Abbruzzese, J. L., & Reddy, S. A. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207902 · Cited by 303
Goel, A., Arnold, C. N., Niedzwiecki, D., Carethers, J. M., Dowell, J. M., Wasserman, L., Compton, C., Mayer, R. J., Bertagnolli, M. M., & Boland, C. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2401-2 · Cited by 302
Goggins, M., Shekher, M. C., Turnacioglu, K. K., Yeo, C. J., Hruban, R. H., & Kern, S. E. (1998) · PubMed · Cited by 288
Nishida, N., Nagasaka, T., Nishimura, T., Ikai, I., Boland, R. C., & Goel, A. (2008) · Hepatology · doi:10.1002/hep.22110 · Cited by 286
Microtubule Binding to Smads May Regulate TGFβ Activity
Dong, C., Li, Z., Alvarez, R., Feng, X.-H., & Goldschmidt-Clermont, P. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80400-1 · Cited by 282
Johnson, B. R., Nitta, R. T., Frock, R. L., Mounkes, L., Barbie, D. A., Stewart, C. L., Harlow, E., & Kennedy, B. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403250101 · Cited by 282
Wichmann, G., Rosolowski, M., Krohn, K., Kreuz, M., Boehm, A., Reiche, A., Scharrer, U., Halama, D., Bertolini, J., Bauer, U., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29649 · Cited by 281
Mutations of the E–cadherin gene in human gynecologic cancers
Risinger, J. I., Berchuck, A., Kohler, M. F., & Boyd, J. (1994) · Nature Genetics · doi:10.1038/ng0594-98 · Cited by 280
Transforming Growth Factor β-Independent Shuttling of Smad4 between the Cytoplasm and Nucleus
Pierreux, C. E., Nicolás, F. J., & Hill, C. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.9041-9054.2000 · Cited by 274
Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
Dong, S. M., Kim, H. S., Rha, S.-H., & Sidransky, D. (2001) · PubMed · Cited by 272
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
Pritchard, C. C., Morrissey, C., Kumar, A., Zhang, X., Smith, C., Coleman, I., Salipante, S. J., Milbank, J., Yu, M., Grady, W. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5988 · Cited by 269
Genetic and epigenetic changes in nasopharyngeal carcinoma
Lo, K.-W., & Huang, D. P. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044579x02000883 · Cited by 269
Disruption of Transforming Growth Factor-β Signaling in ELF β-Spectrin-Deficient Mice
Tang, Y., Katuri, V., Dillner, A., Mishra, B., Deng, C.-X., & Mishra, L. (2003) · Science · doi:10.1126/science.1075994 · Cited by 262
CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer
Teodoridis, J. M., Hall, J., Marsh, S., Kannall, H. D., Smyth, C., Curto, J., Siddiqui, N., Gabra, H., McLeod, H. L., Strathdee, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1187 · Cited by 256
Somatic alterations of the DPC4 gene in human colorectal cancers in vivo
Takagi, Y., Kohmura, H., Futamura, M., Kida, H., Tanemura, H., Shimokawa, K., & Saji, S. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8898652 · Cited by 254
TP53 and gastric carcinoma: A review
Fenoglio-Preiser, C. M., Wang, J., Stemmermann, G. N., & Noffsinger, A. (2003) · Human Mutation · doi:10.1002/humu.10180 · Cited by 252
Somatic LKB1 Mutations Promote Cervical Cancer Progression
Wingo, S. N., Gallardo, T. D., Akbay, E. A., Liang, M.-C., Contreras, C. M., Boren, T., Shimamura, T., Miller, D. S., Sharpless, N. E., Bardeesy, N., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005137 · Cited by 247
Regulation of TGF‐β family signaling by E3 ubiquitin ligases
Inoue, Y., & Imamura, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00925.x · Cited by 246
Marsit, C. J., Zheng, S., Aldape, K., Hinds, P. W., Nelson, H. H., Wiencke, J. K., & Kelsey, K. T. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.05.006 · Cited by 243
Mills, A. M., Liou, S., Ford, J. M., Berek, J. S., Pai, R. K., & Longacre, T. A. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000321 · Cited by 243
Cancer Risks for MLH1 and MSH2 Mutation Carriers
Dowty, J. G., Win, A. K., Buchanan, D. D., Lindor, N. M., Macrae, F. A., Clendenning, M., Antill, Y. C., Thibodeau, S. N., Casey, G., Gallinger, S., et al. (2013) · Human Mutation · doi:10.1002/humu.22262 · Cited by 243
Role of Smad4 (DPC4) inactivation in human cancer
Miyaki, M., & Kuroki, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01066-0 · Cited by 242
Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.
Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T., & Takahashi, T. (1996) · PubMed · Cited by 241
Lüttges, J., Galehdari, H., Bröcker, V., Schwarte-Waldhoff, I., Henne-Bruns, D., Klöppel, G., Schmiegel, W., & Hahn, S. A. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64123-5 · Cited by 241
Abnormalities of the APC/β-catenin pathway in endometrial cancer
Moreno-Bueno, G., Hardisson, D., Sánchez, C., Sarrió, D., Cassia, R., García-Rostán, G., Prat, J., Guo, M., Herman, J. G., Matías-Guiu, X., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205924 · Cited by 237
p14ARF Deletion and Methylation in Genetic Pathways to Glioblastomas
Nakamura, M., Watanabe, T., Klangby, U., Asker, C., Wiman, K., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00388.x · Cited by 237
Promoter Methylation and Silencing of PTEN in Gastric Carcinoma
Kang, Y.-H., Lee, H. S., & Kim, W. H. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780422 · Cited by 231
Regulation of tumor suppressors by nuclear-cytoplasmic shuttling
Fabbro, M., & Henderson, B. R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00019-8 · Cited by 231
Onel, K., & Cordon-Cardo, C. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.1.2.1 · Cited by 226
Promoter methylation of the PTEN gene is a common molecular change in breast cancer
García, J. M., Silva, J., Peña, C., Garcia, V., Rodríguez, R., Cruz, M. A., Cantos, B., Provencio, M., España, P., & Bonilla, F. (2004) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20062 · Cited by 224
Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers.
Huang, Y., Boynton, R. F., Blount, P. L., Silverstein, R., Yin, J., Tong, Y., McDaniel, T. K., Newkirk, C., Resau, J. H., Sridhara, R., et al. (1992) · PubMed · Cited by 221
Edamoto, Y., Hara, A., Biernat, W., Terracciano, L., Cathomas, G., Riehle, H., Matsuda, M., Fujii, H., Scoazec, J., & Ohgaki, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11254 · Cited by 220
Frequent somatic mutations of the APC gene in human pancreatic cancer.
Horii, A., Nakatsuru, S., Miyoshi, Y., Ichii, S., Nagase, H., Ando, H., Yanagisawa, A., Tsuchiya, E., Kato, Y., & Nakamura, Y. (1992) · PubMed · Cited by 217
Xie, W. Q., Mertens, J. C., Reiss, D. J., Rimm, D. L., Camp, R. L., Haffty, B. G., & Reiß, M. (2002) · PubMed · Cited by 217
Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
Brachman, D. G., Graves, D., Vokes, E. E., Beckett, M., Haraf, D. J., Montag, A., Dunphy, E. P., Mick, R., Yandell, D. W., & Weichselbaum, R. R. (1992) · PubMed · Cited by 212
Sarrió, D., Moreno‐Bueno, G., Hardisson, D., Sánchez‐Estévez, C., Guo, M., Herman, J. G., Gamallo, C., Esteller, M., & Palacios, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11197 · Cited by 209
Regulatory mechanisms controlling human E-cadherin gene expression
Liu, Y.-N., Lee, W.-W., Wang, C.-Y., Chao, T.-H., Chen, Y., & Chen, J. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208991 · Cited by 209
Allelotype of pancreatic adenocarcinoma.
Seymour, A. B., Hruban, R. H., Redston, M. S., Caldas, C., Powell, S. M., Kinzler, K. W., Yeo, C. J., & Kern, S. E. (1994) · PubMed · Cited by 203
ras gene mutations in human prostate cancer.
Carter, B. S., Epstein, J. I., & Isaacs, W. B. (1990) · PubMed · Cited by 202
Varley, J. M., Armour, J. A. L., Je, S., Jeffreys, A. J., Ponder, B. A., Tang, A. J., Fung, Y. K., Brammar, W. J., & Ra, W. (1989) · PubMed · Cited by 202
Xing, E. P., Nie, Y., Song, Y., Yang, G., Cai, Y., Wang, L., & Yang, C. S. (1999) · PubMed · Cited by 195
Self-citationXu, X.-L. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i23.3441 · Cited by 191
Marshall, F. F. (2005) · Journal of Urology · doi:10.1097/01.ju.0000187488.30867.11 · Cited by 191
Wang, Z. C., Lin, M., Wei, L.-J., Li, C., Miron, A., Lodeiro, G., Harris, L., Ramaswamy, S., Tanenbaum, D. M., Meyerson, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2570 · Cited by 190
Promoter Hypermethylation of FANCF
Narayan, G., Arias-Pulido, H., Nandula, S. V., Basso, K., Sugirtharaj, D. D., Vargas, H., Mansukhani, M., Villella, J., Meyer, L., Schneider, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0245 · Cited by 190
The NF1 gene revisited - from bench to bedside
Yap, Y.-S., McPherson, J. R., Ong, C.-K., Rozen, S. G., Teh, B.-T., Lee, A. S. G., & Callen, D. F. (2014) · Oncotarget · doi:10.18632/oncotarget.2194 · Cited by 189
Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel
Dulaimi, E., Uzzo, R. G., Greenberg, R. E., Al-Saleem, T., & Cairns, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0127 · Cited by 188
The ARF tumor suppressor: Structure, functions and status in cancer
Ozenne, P., Eymin, B., Brambilla, E., & Gazzeri, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25511 · Cited by 183
Chen, Y.-B., Xu, J., Skanderup, A. J., Dong, Y., Brannon, A. R., Wang, L., Won, H. H., Wang, P. I., Nanjangud, G. J., Jungbluth, A. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms13131 · Cited by 181
Self-citationKruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer☆
Reeves, H. L., Narla, G., Ogunbiyi, O., Haq, A. I., Katz, A., Benzeno, S., Hod, E., Harpaz, N., Goldberg, S., & Tal-Kremer, S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.005 · Cited by 179
Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine Neoplasms
House, M. G., Herman, J. G., Guo, M. Z., Hooker, C. M., Schulick, R. D., Lillemoe, K. D., Cameron, J. L., Hruban, R. H., Maitra, A., & Yeo, C. J. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000086659.49569.9e · Cited by 178
Tian, F., Byfield, S. D., Parks, W. T., Yoo, S. S., Felici, A., Tang, B., Piek, E., Wakefield, L. M., & Roberts, A. B. (2003) · PubMed · Cited by 177
Inactivation of HAUSP in vivo modulates p53 function.
Kon, N., Kobayashi, Y., Li, M., Brooks, C. L., Ludwig, T., & Gu, W. (2010) · Oncogene · doi:10.1038/onc.2009.427 · Cited by 176
McNerney, M. E., Brown, C. D., Wang, X., Bartom, E. T., Karmakar, S., Bandlamudi, C., Yu, S., Ko, J., Sandall, B. P., Stricker, T. P., et al. (2012) · Blood · doi:10.1182/blood-2012-04-426965 · Cited by 172
Promoter Hypermethylation Profile of Kidney Cancer
Dulaimi, E., de Cáceres, I. I., Uzzo, R. G., Al‐Saleem, T., Greenberg, R. E., Polascik, T. J., Babb, J. S., Grizzle, W. E., & Cairns, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0175 · Cited by 172
Yu, J., Ni, M., Xu, J., Zhang, H., Gao, B., Gu, J., Chen, J., Zhang, L., Wu, M., Zhen, S., et al. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-29 · Cited by 170
Massively regulated genes: the example of TP53
Hollstein, M. C., & Hainaut, P. L. (2009) · The Journal of Pathology · doi:10.1002/path.2637 · Cited by 170
Zhang, X., Xu, H. J., Murakami, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S., Benedict, W. F., & Sekiya, T. (1994) · PubMed · Cited by 168
Potapova, T. A., Zhu, J., & Li, R. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9436-6 · Cited by 168
TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance
PELLER, S., & Rotter, V. (2003) · Human Mutation · doi:10.1002/humu.10190 · Cited by 168
Smad2 and Smad4 gene mutations in hepatocellular carcinoma
Yakicier, M. C., Irmak, M. B., Romano, A., Kew, M., & Ozturk, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202866 · Cited by 167
USP4 inhibits p53 through deubiquitinating and stabilizing ARF‐BP1
Zhang, X., Berger, F. G., Yang, J., & Lu, X. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.125 · Cited by 166
Expression of Androgen Receptor Coregulators in Prostate Cancer
Linja, M. J., Porkka, K. P., Kang, Z., Savinainen, K., Jänne, O. A., Tammela, T. L. J., Vessella, R. L., Palvimo, J. J., & Visakorpi, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0990-3 · Cited by 166
The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma.
Shen, Z., Wen, X. F., Lan, F., Shen, Z. Z., & Shao, Z. M. (2002) · PubMed · Cited by 164
Meltzer, S. J., Yin, J., Huang, Y., McDaniel, T. K., Newkirk, C., Iseri, O., Vogelstein, B., & Resau, J. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4976 · Cited by 164
Epigenetic regulation in cancer progression
Baxter, E., Windloch, K., Gannon, F., & Lee, J. S. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-45 · Cited by 164
DNA mismatch repair defects: role in colorectal carcinogenesis.
Jacob, S., & Praz, F. (2002) · Biochimie · doi:10.1016/s0300-9084(01)01362-1 · Cited by 163
Brito, M. B., Goulielmaki, E., & Papakonstanti, E. A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00166 · Cited by 162
Schuijer, M., & Berns, E. M. J. J. (2003) · Human Mutation · doi:10.1002/humu.10181 · Cited by 160
Kim, S. K., Fan, Y.-H., Papadimitrakopoulou, V. A., Clayman, G. L., Hittelman, W. N., Hong, W. K., Lotan, R., & Mao, L. (1996) · PubMed · Cited by 159
Song, H., Cicek, M. S., Dicks, E., Harrington, P. A., Ramus, S. J., Cunningham, J. M., Fridley, B. L., Tyrer, J. P., Alsop, J., Jimenez‐Liñan, M., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu172 · Cited by 158
Yang, H., Liu, V. W. S., Wang, Y., Tsang, P. C. K., & Ngan, H. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-212 · Cited by 155
House, M. G., Guo, M., Iacobuzio-Donahue, C., & Herman, J. G. (2003) · Carcinogenesis · doi:10.1093/carcin/24.2.193 · Cited by 154
Biswas, S., Chytil, A. M., Washington, K., Romero–Gallo, J., Gorska, A. E., Wirth, P. S., Gautam, S., Moses, H. L., & Grady, W. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3255 · Cited by 153
Phillips, S. M. A., Barton, C., Lee, S. J., Morton, D. G., Wallace, D., Lemoine, N. R., & Neoptolemos, J. P. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.482 · Cited by 152
Thompson, A. M., Anderson, T. J., Condie, A., Prosser, J., Chetty, U., Carter, D. C., Evans, H. J., & Steel, C. M. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500405 · Cited by 147
PTEN regulation by Akt–EGR1–ARF–PTEN axis
Yu, J., Zhang, S. S., Saito, K., Williams, S., Arimura, Y., Ma, Y., Ke, Y., Baron, V. T., Mercola, D., Feng, G., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.238 · Cited by 147
Ebert, M. P. A., Fei, G., Kahmann, S., Müller, O., Yu, J., Sung, J. J. Y., & Malfertheiner, P. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.87 · Cited by 144
Ubiquitin‐mediated control of oncogene and tumor suppressor gene products
Kitagawa, K., Kotake, Y., & Kitagawa, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01196.x · Cited by 142
Promoter Hypermethylation Profile of Ovarian Epithelial Neoplasms
Makarla, P., Saboorian, M. H., Ashfaq, R., Toyooka, K. O., Toyooka, S., Minna, J. D., Gazdar, A. F., & Schorge, J. O. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2455 · Cited by 142
Kremer-Tal, S., Reeves, H. L., Narla, G., Thung, S. N., Schwartz, M., DiFeo, A. V., Katz, A. M., Bruix, J., Bioulac‐Sage, P., Martignetti, J. A., et al. (2004) · Hepatology · doi:10.1002/hep.20460 · Cited by 141
Regulation of p53: a collaboration between Mdm2 and MdmX
Pei, D., Zhang, Y., & Zheng, J. (2012) · Oncotarget · doi:10.18632/oncotarget.443 · Cited by 140
Chen, L., Neubauer, A., Kurisu, W., Waldman, F. M., Ljung, B., Goodson, W. H., Goldman, E. S., Moore, D. H., Balázs, M., & Liu, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3847 · Cited by 140
Gao, X., Honn, K. V., Grignon, D. J., Sakr, W., & Chen, Y. Q. (1993) · PubMed · Cited by 139
PTEN methylation and expression in glioblastomas
Baeza, N., Weller, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0748-4 · Cited by 139
Deletion, Mutation, and Loss of Expression of KLF6 in Human Prostate Cancer
Chen, C., Hyytinen, E., Sun, X., Helin, H. J., Koivisto, P. A., Frierson, H. F., Vessella, R. L., & Dong, J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63930-2 · Cited by 137
Biological activity of probable/possible high‐risk human papillomavirus types in cervical cancer
Halec, G., Schmitt, M., Dondog, B., Sharkhuu, E., Wentzensen, N., Gheit, T., Tommasino, M., Kommoss, F., Bosch, F. X., Franceschi, S., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27605 · Cited by 137
Wada, C., Shionoya, S., Fujino, Y., Tokuhiro, H., Akahoshi, T., Uchida, T., & Ohtani, H. (1994) · Blood · doi:10.1182/blood.v83.12.3449.3449 · Cited by 137
Kang, S. H., Bang, Y., Im, Y., Yang, H.-K., Lee, D. A., Lee, H. Y., Lee, H. S., Kim, N. K., & Kim, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203146 · Cited by 136
An uncertain role for p53 gene alterations in human prostate cancers.
Brooks, J. D., Bova, G. S., Ewing, C. M., Piantadosi, S., Carter, B. S., Robinson, J. C., Epstein, J. I., & Isaacs, W. B. (1996) · PubMed · Cited by 130
Höhne, M. W., Halatsch, M., Kahl, G. F., & Weinel, R. J. (1992) · PubMed · Cited by 128
Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer
Gill, R. K., Yang, S.-H., Meerzaman, D. M., Mechanic, L. E., Bowman, E. D., Jeon, H.-S., Roy‐Chowdhuri, S., Shakoori, A., Dracheva, T., Hong, K.-M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.98 · Cited by 126
Genetic and epigenetic alterations as hallmarks of the intricate road to cancer
Macaluso, M., Paggi, M. G., & Giordano, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206955 · Cited by 126
Spotlight on the role of COP1 in tumorigenesis
Marine, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3271 · Cited by 126
Microsatellite instability and alterations in the HMSH2 gene in human ovarian cancer
Fujita, M., Enomoto, T., Yoshino, K., Nomura, T., Buzard, G. S., Inoue, M., & Okudaira, Y. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640602 · Cited by 125
Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus
Robertson, K. D., & Jones, P. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202737 · Cited by 125
Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas
MacGrogan, D., Pegram, M. D., Slamon, D. J., & Bookstein, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201232 · Cited by 125
Methylation Profiling of Archived Non–Small Cell Lung Cancer: A Promising Prognostic System
Safar, A. M., Spencer, H. J., Su, X., Coffey, M., Cooney, C. A., Ratnasinghe, L. D., Hutchins, L. F., & Fan, C. Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2378 · Cited by 124
Yu, J., Zhang, H., Gu, J. F., Lin, S., Li, J., Lu, W., Wang, Y., & Zhu, J. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-65 · Cited by 123
BRCA1 methylation: a significant role in tumour development?
Catteau, A., & Morris, J. R. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00056-1 · Cited by 122
Mutation of the 9q34 gene TSC1 in sporadic bladder cancer
Hornigold, N., Devlin, J., Davies, A. M., Aveyard, J. S., Habuchi, T., & Knowles, M. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202854 · Cited by 121
Xie, W. Q., Rimm, D. L., Lin, Y., Shih, W. J., & Reiß, M. (2003) · The Cancer Journal · doi:10.1097/00130404-200307000-00013 · Cited by 121
Wang, D., Kanuma, T., Mizunuma, H., Takama, F., Ibuki, Y., Wake, N., Mogi, A., Shitara, Y., & Takenoshita, S. (2000) · PubMed · Cited by 121
Biallelic inactivation of the APC gene in hepatoblastoma.
Kurahashi, H., Takami, K., Oue, T., Kusafuka, T., Okada, A., Tawa, A., Okada, S., & Nishisho, I. (1995) · PubMed · Cited by 120
Ho, D. W., Chan, L., Chiu, Y. T., Xu, M., Poon, R. T. P., Cheung, T. T., Tang, C. N., Tang, V. W., Lo, I. L., Lam, P. W. Y., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312734 · Cited by 120
伊藤, 源. (2005) · 名古屋大学 eBooks · Cited by 119
Beckmann, M., Picard, F., An, H., van Roeyen, C. R. C., Dominik, S., Mosny, D., Schnürch, H.-G., Bender, H., & Niederacher, D. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.234 · Cited by 119
Targeting nucleocytoplasmic transport in cancer therapy
Hill, R., Cautain, B., de Pedro, N., & Link, W. (2013) · Oncotarget · doi:10.18632/oncotarget.1457 · Cited by 119
Shintani, S., Nakahara, Y., Mihara, M., Ueyama, Y., & Matsumura, T. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00142-1 · Cited by 118
Loss of Stk11/Lkb1 Expression in Pancreatic and Biliary Neoplasms
Sahin, F., Maitra, A., Argani, P., Sato, N., Maehara, N., Montgomery, E. A., Goggins, M., Hruban, R. H., & Su, G. H. (2003) · Modern Pathology · doi:10.1097/01.mp.0000075645.97329.86 · Cited by 118
Silva, J., Silva, J. M., Domínguez, G., García, J. M., Cantos, B., Rodríguez, R., Larrondo, F. J., Provencio, M., España, P., & Bonilla, F. (2003) · The Journal of Pathology · doi:10.1002/path.1297 · Cited by 116
Cybulski, C., Wokołorczyk, D., Huzarski, T., Byrski, T., Gronwald, J., Górski, B., Dębniak, T., Masojć, B., Jakubowska, A., Gliniewicz, B., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.044974 · Cited by 115
Functional Mechanisms for Human Tumor Suppressors
Sun, W., & Yang, J. P. (2010) · Journal of Cancer · doi:10.7150/jca.1.136 · Cited by 115
Berggren, P., Kumar, R., Sakano, S., Hemminki, L., Wada, T., Steineck, G., Adolfsson, J., Larsson, P., Norming, U., Wijkström, H., et al. (2003) · PubMed · Cited by 114
Kang, J. H., Kim, S. J., Noh, D., Park, I. A., Choe, K. J., Yoo, O. J., & Kang, H. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780266 · Cited by 113
Wang, C.-J., Horiuchi, A., Imai, T., Ohira, S., Itoh, K., Nikaido, T., Katsuyama, Y., & Konishi, I. (2004) · The Journal of Pathology · doi:10.1002/path.1507 · Cited by 112
Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression
Wang, L., Kim, S.-H., Lee, J. H., Choi, Y., Kim, Y. C., Park, T. S., Hong, Y., Wu, C., & Shin, Y. K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1467 · Cited by 112
Self-citationMolecular profiling of head and neck squamous cell carcinoma
Feldman, R. A., Gatalica, Z., Knezetic, J. A., Reddy, S. K., Nathan, C. O., Javadi, N., & Teknos, T. N. (2015) · Head & Neck · doi:10.1002/hed.24290 · Cited by 112
SMAD4 and its role in pancreatic cancer
Xia, X., Wu, W., Huang, C., Cen, G., Jiang, T., Cao, J., Huang, K., & Qiu, Z. (2014) · Tumor Biology · doi:10.1007/s13277-014-2883-z · Cited by 111
Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
Phillips, N. J., Ziegler, M. R., Radford, D. M., Fair, K., Steinbrueck, T., Xynos, F. P., & Donis-Keller, H. (1996) · PubMed · Cited by 110
Tsuruta, H., Kishimoto, H., Sasaki, T., Horie, Y., Natsui, M., Shibata, Y., Hamada, K., Yajima, N., Kawahara, K., Sasaki, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4627 · Cited by 109
BRCA1 and BRCA2 mutations and the risk for colorectal cancer
Sopik, V., Phelan, C., Cybulski, C., & Narod, S. A. (2014) · Clinical Genetics · doi:10.1111/cge.12497 · Cited by 108
Copland, J. A., Luxon, B. A., Ajani, L., Maity, T., Campagnaro, E. L., Guo, H., LeGrand, S. N., Tamboli, P., & Wood, C. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206835 · Cited by 107
Bignell, G. R., Barfoot, R., Seal, S., Collins, N., Warren, W., & Stratton, M. R. (1998) · PubMed · Cited by 106
Zhang, W., Gao, Y., Li, F., Tong, X., Ren, Y., Han, X., Yao, S., Long, F., Yang, Z., Fan, H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3396 · Cited by 104
Zhang, X., Li, M., Zuo, K., Li, D., Ye, M., Ding, L., Cai, H., Fu, D., Fan, Y., & Lv, Z. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3602 · Cited by 104
Murata, H., Khattar, N. H., Kang, Y., Gu, L., & Li, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205683 · Cited by 103
Tanaka, Y., Terai, Y., Kawaguchi, H., Fujiwara, S., Yoo, S., Tsunetoh, S., Takai, M., Kanemura, M., Tanabe, A., & Ohmichi, M. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.22625 · Cited by 103
Regulation of the p14ARF-Mdm2-p53 pathway: An overview in breast cancer
Agrawal, A., Yang, J., Murphy, R. F., & Agrawal, D. K. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.07.001 · Cited by 103
BREWSTER, S. F., Browne, S. J., & Brown, K. W. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)35186-8 · Cited by 102
Jiang, W. G., Sampson, J. R., Martin, T. A., Lee‐Jones, L., Watkins, G., Douglas-Jones, A. G., Mokbel, K., & Mansel, R. E. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.023 · Cited by 100
Buck, M. B., Fritz, P., Dippon, J., Zugmaier, G., & Knabbe, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0320-03 · Cited by 100
Chakraborty, S., Mohiyuddin, S. M. A., Gopinath, K., & Kumar, A. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-163 · Cited by 100
Structural alterations of transforming growth factor-? receptor genes in human cervical carcinoma
Chen, T., de Vries, E. G. E., Hollema, H., Yegen, H. A., Vellucci, V. F., Strickler, H. D., Hildesheim, A., & Reiss, M. (1999) · International Journal of Cancer · Cited by 100
Retinoblastoma gene mutations in primary human prostate cancer
Kubota, Y., Fujinami, K., Uemura, H., Dobashi, Y., Miyamoto, H., Iwasaki, Y., Kitamura, H., & Shuin, T. (1995) · The Prostate · doi:10.1002/pros.2990270604 · Cited by 98
Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors
Domínguez, G., Silva, J., Garcia, J. M., Silva, J. M., Rodríguez, R., Muñoz, C., Chacón, I., Sanchez, R., Carballido, J., Colás, A., et al. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(03)00133-7 · Cited by 98
Functional evaluation of p53 and PTEN gene mutations in gliomas.
Kato, H., Kato, S., Kumabe, T., Sonoda, Y., Yoshimoto, T., Kato, S., Han, S., Suzuki, T., Shibata, H., Kanamaru, R., et al. (2000) · PubMed · Cited by 98
Loss of heterozygosity analysis: Practically and conceptually flawed?
Tomlinson, I. P. M., Lambros, M. B. K., Roylance, R. R., & Cleton-Jansen, A. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10085 · Cited by 97
Microsatellite Instability and Mutation of DNA Mismatch Repair Genes in Gliomas
Leung, S. Y., Chan, T. L., Chung, L.-P., Chan, A. S. Y., Fan, Y. W., Hung, K. N., Kwong, W. K., Ho, J. W. C., & Yuen, S. T. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65662-3 · Cited by 97
Deciphering the BRCA1 Tumor Suppressor Network
Jiang, Q., & Greenberg, R. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.667931 · Cited by 96
Liu, Y., Székely, L., Grandér, D., Söderhäll, S., Juliusson, G., Gahrton, G., Linder, S., & Einhorn, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8697 · Cited by 96
Genetic alterations of the KLF6 gene in gastric cancer
Cho, Y. G., Kim, C. J., Park, C. H., Yang, Y. M., Kim, S. Y., Nam, S. W., Lee, S. H., Yoo, N. J., Lee, J. Y., & Park, W. S. (2005) · Oncogene · doi:10.1038/sj.onc.1208670 · Cited by 96
Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain
Rodríguez, J. A., Au, W. W. Y., & Henderson, B. R. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.027 · Cited by 96
Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms
Cho, E. Y., Choi, Y., Chae, S. W., Sohn, J. H., & Ahn, G. (2006) · Pathology International · doi:10.1111/j.1440-1827.2006.01925.x · Cited by 96
Cited by
Turner, M. C., Andersen, Z. J., Baccarelli, A., Diver, W. R., Gapstur, S. M., Pope, C. A., Prada, D., Samet, J., Thurston, G., & Cohen, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21632 · Cited by 844
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
RosettaDDGPrediction for high‐throughput mutational scans: From stability to binding
(2022) · doi:10.1002/pro.4527 · Cited by 90
Ansari, M. A., Thiruvengadam, M., Venkidasamy, B., Alomary, M. N., Salawi, A., Chung, I.-M., Shariati, M. A., & Rebezov, M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.005 · Cited by 63
Zhong, G., Zhao, Y., Zhuang, D., Chung, W. K., & Shen, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-62318-4 · Cited by 15
Metadata
- Authors
- Wang, L.-H., Wu, C.-F., Rajasekaran, N., & Shin, Y. K.
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 51
- Issue
- 6
- Pages
- 2647-2693
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2903826068
- Cited by
- 334
- References
- 481
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.